As of Mar 26
| +1.18 / +1.37%|
The 2 analysts offering 12-month price forecasts for China Biologic Products Inc have a median target of 93.20, with a high estimate of 96.40 and a low estimate of 90.00. The median estimate represents a +6.73% increase from the last price of 87.32.
The current consensus among 2 polled investment analysts is to Buy stock in China Biologic Products Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.